These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 34439356)
1. Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma. Kotiyal S; Evason KJ Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439356 [TBL] [Abstract][Full Text] [Related]
2. A systematic analysis with the hierarchical cluster analysis strategy on the complex interaction of TERT and CTNNB1 somatic mutations in Vietnamese hepatocellular carcinoma patients. Thu Nguyen T; Van Tran K; Cam Ho T; Xuan Nguyen H; Trong Nguyen T Gene; 2024 Nov; 927():148646. PubMed ID: 38851365 [TBL] [Abstract][Full Text] [Related]
3. CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence. Ambrozkiewicz F; Trailin A; Červenková L; Vaclavikova R; Hanicinec V; Allah MAO; Palek R; Třeška V; Daum O; Tonar Z; Liška V; Hemminki K BMC Cancer; 2022 Aug; 22(1):884. PubMed ID: 35962322 [TBL] [Abstract][Full Text] [Related]
4. Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Pezzuto F; Izzo F; Buonaguro L; Annunziata C; Tatangelo F; Botti G; Buonaguro FM; Tornesello ML Oncotarget; 2016 Aug; 7(34):54253-54262. PubMed ID: 27276713 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features. Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052 [TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma. Pezzuto F; Izzo F; De Luca P; Biffali E; Buonaguro L; Tatangelo F; Buonaguro FM; Tornesello ML Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359670 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus-Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma. Sze KM; Ho DW; Chiu YT; Tsui YM; Chan LK; Lee JM; Chok KS; Chan AC; Tang CN; Tang VW; Lo IL; Yau DT; Cheung TT; Ng IO Hepatology; 2021 Jan; 73(1):23-40. PubMed ID: 32170761 [TBL] [Abstract][Full Text] [Related]
9. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192 [TBL] [Abstract][Full Text] [Related]
10. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529 [TBL] [Abstract][Full Text] [Related]
11. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability. Ueda Y; Hiyama E; Kamimatsuse A; Kamei N; Ogura K; Sueda T J Pediatr Surg; 2011 Dec; 46(12):2221-7. PubMed ID: 22152854 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression. Midorikawa Y; Yamamoto S; Tatsuno K; Renard-Guillet C; Tsuji S; Hayashi A; Ueda H; Fukuda S; Fujita T; Katoh H; Ishikawa S; Covington KR; Creighton CJ; Sugitani M; Wheeler DA; Shibata T; Nagae G; Takayama T; Aburatani H Cancer Res; 2020 Sep; 80(18):3810-3819. PubMed ID: 32641413 [TBL] [Abstract][Full Text] [Related]
13. Identification of genes involved in the regulation of TERT in hepatocellular carcinoma. Amisaki M; Tsuchiya H; Sakabe T; Fujiwara Y; Shiota G Cancer Sci; 2019 Feb; 110(2):550-560. PubMed ID: 30447097 [TBL] [Abstract][Full Text] [Related]
14. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868 [TBL] [Abstract][Full Text] [Related]